共查询到20条相似文献,搜索用时 15 毫秒
1.
Objective To clarify the clinicopathological features of renal amyloidosis in order to achieve early diagnosis and treatment. Methods Clinicopathological data of 26 biopsy-proven renal amyloidosis cases in Department of Nephrology, Zhongshan Hospital, Fudan University between 2006 and 2010 were analyzed retrospectively. Immunohistochemistry and immunofluorescence of amyloid A protein, immunoglobulin light chains such as ?资、?姿 were performed on renal specimens for further classification. Results Age of 26 patients ranged from 40 to 77 years old, average (58.54±10.07) years. Twenty-two out of 26 patients (84.62%) were treated in local hospital before admitted to our department, and 21 patients (95.45%) were misdiagnosed as chronic primary glomerulonephritis. The prominent clinical manifestations of renal amyloidosis were nephrotic syndrome (17 cases, 65.38%), decreased blood pressure (16 cases, 61.53%), organ enlargement (8 cases, 30.77%) and bodyweight loss (6 cases, 23.08%). Fourteen out of 25 patients (56.00%) were found to have monoclonal light chains in serum by immunofixation electrophoresis. Three patients with mild pathological changes who had no confirmable Congo red stain were confirmed by electron microscopy. Twenty-three (88.46%) patients were diagnosed as AL amyloidosis, one (3.85%) as AA amyloidosis, one was strongly suspected of hereditary amyloidosis, and one was undetermined. Conclusions Renal amyloidosis is frequently misdiagnosed. Middle-aged and old nephrotic patients with decreased blood presure, organ enlargement and bodyweight loss may be the most helpful clues of the disease. Most patients have monoclonal light chains in serum or urine. Renal biopsy, especially electronic microscopy plays a crucial role in the early diagnosis of renal amyloidosis. Immunohistochemistry is important for patients with renal amyloidosis in pathological classification and treatment. 相似文献
2.
3.
目的:回顾性观察本中心2003—2019年收治的以肾脏病为首发表现的淀粉样变患者51例,总结其临床、病理特征并进行相关性分析.方法:收集患者基本资料、实验室检查结果、病理资料及中医证候进行统计分析.结果:51例患者中25例(49.02%)呈肾病综合征表现,13例(25.49%)患者起病时即有肾衰竭,11例(21.57%... 相似文献
4.
5.
6.
7.
淀粉样变是由淀粉样物质沉积于组织或器官而引发的疾病,累及肾脏多见。肾淀粉样变过去被认为是一种罕见且难治的疾病。然而,近几年肾淀粉样变的发病率呈逐年上升的趋势,每年达2.1~3.3人/1000000,占肾活检患者的0.59/6~1.0%,可见肾淀粉样变并不少见。 相似文献
8.
9.
10.
淀粉样变是以细胞外淀粉样蛋白沉积为特点的一类疾病,累及肾脏者称为肾淀粉样变。肾淀粉样变典型表现为肾病综合征和肾功能进行性恶化进展至终末期肾脏病(end stage renal disease,ESRD)。该病在临床并不罕见。本文就其病因及诊断治疗等方面进展做简单介绍。 相似文献
11.
12.
骨内型骨淀粉样变病(附1例报告)王鹏池,吴迪,王书明,荣秀东骨淀粉样变极为罕见,国内外文献报道甚少,作者等最近遇到1例不伴有关节与其它组织病变的骨内型淀粉样变,此类型国内外尚未见有报告,今将病例介绍如下:1病例报告男性,65岁,于1年前无明显诱因出现... 相似文献
13.
14.
张育安 《国际泌尿系统杂志》2013,33(2):264-270
肾淀粉样变性病是肾病科一种顽固、预后凶险的疾病,需要及早诊断和干预,它也是淀粉样变性病患者死亡的主要原因之一.本文拟从该病肾脏病理损伤的发病机制、病理评分系统、病理诊断、病理特点与临床表现的相关性和新的诊断技术LMD/MS在该病中的应用等方面的研究进展作一综述. 相似文献
15.
患者,男,44岁。2年前出现终末肉眼血尿,可自行消失。2007年1月因大便后外尿道口滴血在当地医院诊治,CT表现:膀胱左、前侧壁不规则增厚,最厚14mm,增强扫描见病变中度强化,CT值为52HU。膀胱镜检并取黏膜活检诊断为“出血性膀胱炎”,抗感染止血治疗后症状消失。同年8月再因大便后外尿道口滴血及尿中血凝块入院诊治。 相似文献
16.
目的:探讨膀胱淀粉样变术前误诊为膀胱癌的重要因素,总结诊治经验。方法:回顾性分析本院2017年收治的1例膀胱淀粉样变患者的临床资料。结果:行经尿道电切术(TUR),术后膀胱灌注0.01%呋喃西林,随访2年,未见肉眼血尿及复发。结论:膀胱淀粉样变临床上罕见,极易误诊为膀胱癌,确诊需要根据临床表现、影像学检查、病理学检查及... 相似文献
17.
目的 报道1例罕见的Castleman病继发肾淀粉样变性,并进行相关文献复习。方法与结果 1例43岁男性病例,3年前因水肿、蛋白尿住院,经肾活检病理证实为AA型肾淀粉样变性,住院期间发现纵隔淋巴结肿大、血液及骨髓异常。出院后追踪观察,3年后因体表多部位淋巴结肿大而再次住院。经免疫学及淋巴结活检病理检查证实为多中心性浆细胞型Castleman病,与文献报道相符。结论 Castleman病可继发AA型肾淀粉样变性,其发病可能与Castleman病导致的免疫异常有关。 相似文献
18.
19.
目的:了解我院近10年肾活检患者临床和病理特征及疾病谱的变迁。方法:回顾性分析我院2009年06月—2019年05月间的1 136例肾活检患者的临床病理资料,对本院肾脏病的临床病理特征进行分析。结果:1 136例肾活检患者男女比例为1.03∶1,其中膜性肾病(MN)、糖尿病肾病(DN)等男性多于女性,狼疮性肾炎(LN)女性多于男性。肾活检病理类型以原发性肾小球病(PGD)(87.50%)为主,其次为继发性肾小球病(SGD)(11.27%)。PGD病理类型最常见的为IgA肾病(IgAN)(34.00%)和MN(29.98%),SGD最常见的为LN(32.81%)和DN(21.09%)。PGD最常见的临床表现为肾病综合征(NS)和肾炎综合征,其中NS病理类型以MN为主;肾炎综合征、肾衰竭和无症状性蛋白尿和(或)血尿(AUA)均以IgAN为主。近10年间,MN占比由19.30%升至39.03%,超越IgAN跃居至第一位。前5年SGD患者以LN(41.67%)为主,后5年以DN(26.47%)和LN(25.00%)为主。结论:PGD是肾活检患者最常见的疾病类型,以IgAN为主,MN比例增加明显... 相似文献